Page last updated: 2024-10-22

aminoglutethimide and Inappropriate ADH Syndrome

aminoglutethimide has been researched along with Inappropriate ADH Syndrome in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Solomon, CG1
Dluhy, RG1
Box, M1
Saltissi, D1
Fawcett, D1

Other Studies

2 other studies available for aminoglutethimide and Inappropriate ADH Syndrome

ArticleYear
Paraneoplastic endocrine syndromes.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndr

1994
Inappropriate secretion of antidiuretic hormone following aminoglutethimide therapy.
    British journal of urology, 1986, Volume: 58, Issue:6

    Topics: Aged; Aminoglutethimide; Humans; Inappropriate ADH Syndrome; Male; Prostatic Neoplasms

1986